MAGEA1 and neoplasm: At non-tumour sites, expression of KK-LC-1 and MAGE-A1 was detected in five and one out of 24 patients, from whom the tumour site and one non-tumour site was sampled, respectively, of which tumour sites in the same patients all expressed each CTA (Fig. 1a).